Phenylbutazone toxicity: Depression of erythropoiesis
- 1 April 1958
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 1 (2), 174-177
- https://doi.org/10.1002/art.1780010210
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phenylbutazone in rheumatoid arthritisJournal of Chronic Diseases, 1957
- An Evaluation of Phenylbutazone (Butazolidin) in the Treatment of Gout, Rheumatoid Spondylitis, Rheumatoid Arthritis, and other Conditions of the Musculoskeletal SystemSouthern Medical Journal, 1957
- The Toxic Effects of Phenylbutazone (Butazolidin)New England Journal of Medicine, 1955
- Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisoneAmerican Journal Of Medicine, 1954
- PHENYLBUTAZONEA.M.A. Archives of Internal Medicine, 1953
- FATALITY DUE TO AGRANULOCYTOSIS FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN®)JAMA, 1953
- BENEFITS AND TOXICITY OF PHENYLBUTAZONE (BUTAZOLIDIN®) IN RHEUMATOID ARTHRITISJAMA, 1952